Clinical Trials Sponsored by Institut de Génétique Moléculaire de Montpellier

Total 194 results

Centre Hospitalier Universitaire de Nīmes
Institut de Génétique Moléculaire de Montpellier

Recruiting

Bioclinical Evaluation of 2 Biomarkers of Aviremic HIV-1 in CD4+ T Cells of Adults Undergoing Treatment (RESERVIH32)

HIV-1-infection

France
University Hospital, Montpellier
University of Sydney; Institut de Génétique Moléculaire de Montpellier

Recruiting

Fibres Supplementation in Rheumatoid Arthritis (SUPER-FIBRES)

Rheumatoid Arthritis

France
University Hospital, Montpellier
Centre Hospitalier Universitaire de Nīmes; Institut de Génétique Moléculaire...

Completed

Characterization of Breg Cells (Breg)

Arthritis, Rheumatoid | Healthy Volunteers

France
University Hospital, Montpellier
Institut de Génomique Fonctionnelle (IGF) de Montpellier

Not yet recruiting

Plasma Beta-endorphin Levels and Suicidal Behavior (BEST)

Depression | Suicide | Beta Endorphin

France
Centre Hospitalier Régional d'Orléans
Laboratoire de Virologie Moléculaire de Montpellier

Terminated

Tracking and Exploring the Source of Viral REbound (TESOVIR)

Hiv

France
University Hospital, Montpellier
Institut de Recherche en Cancérologie de Montpellier (IRCM)

Unknown

Chemoresistance and Involvement of the NOTCH Pathway in Patients With Lung Adenocarcinoma (NOTCH)

Lung Adenocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability (PROBA)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Impact of an Educational Physiotherapy-Yoga Intervention on Perceived Stress in Women Treated With Brachytherapy for Cervical Cancer (KYOCOL)

Cervical Cancer | Brachytherapy
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Feasibility of 2 Interventions to Reduce Fatigue in Patients With Chemotherapy for Metastatic Colorectal Cancer (COLOFIGHT)

Colorectal Cancer Metastatic

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Evaluation of the Efficacy of a Physical Therapy-yoga-patient Educational Program for Breast Cancer Patients With Pain Due to Hormonal Therapy Treatment. (SKYPE2)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Establishment of a Prospective Clinical-biological Database (BCBSarcome)

Sarcoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Clinical Database of Safe Personalized Adjuvant Breast Radiotherapy Based on Individual Radiosensitivity (SAHARA-01)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Development of Clinical and Biological Database in Colorectal Cancer (CIRCUS)

Metastatic Colon Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Analysis of Circulating Tumor Markers in Blood (ALCINA 2)

Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Impact of Cardiac Coherence on Anxiety in Patients Operated on for a Peritoneal Carcinosis (COCOON)

Pseudomyxoma Peritonei | Peritoneal Carcinomatosis | Mesothelioma Peritoneum

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessing a Regorafenib-irinotecan Combination Versus Regorafenib Alone in Metastatic Colorectal Cancer Patients (NEXT-REGIRI)

Metastatic Colorectal Cancer (mCRC)

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Safety, Tolerability and Efficacy of Regorafenib in Combination With FOLFIRINOX in Patients With Colorectal Cancer (FOLFIRINOX-R)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Pain Monitoring After Breast Biopsy: Benefit of E-health (BIO-PSY)

Breast Cancer | Biopsy Wound

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Detection of the Emergence of RAS (Rat Sarcoma Viral Oncogene Homolog) Mutations in Circulating DNA (Deoxyribonucleic Acid) in Patients With mCRC (Metastatic Colorectal Cancer) During Treatment With Anti-EGFR (Epidermal Growth Factor Receptor) Therapy (EmutRAS)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

A Phase II Trial Evaluating an Organ-conserving Strategy by Radiochemotherapy for Muscle-infiltrative Bladder Cancer (GETUGV04)

Infiltrating Bladder Urothelial Carcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Intraoperative Radiotherapy After Local Recurrence in Breast Cancer (RE-IORT01)

Breast Carcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Management of Perioperative Anxiety by the Cardiac Coherence Technique Coupled With a Hypnosis Session (COHEC)

Breast Cancer | Gynecologic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Breast-Conserving Surgery and Whole-Breast Radiation Therapy With or Without Additional Radiation Therapy to the Tumor in Treating Women With Ductal Carcinoma in Situ (BONBIS) (BONBIS)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Observational Study of Intra-operative Partial Irradiation of Invasive Ductal Breast Carcinomas With a Good Prognosis (INTRA-OBS)

Invasive Breast Cancer | Breast-conserving Surgery

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

Analysis of cfDNA in Patients With Hepatocarcinoma and Treated by Sorafenib or Regorafenib (HELP)

Hepatocarcinoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Precoce Medical Care by the Mobil Support for Patients With Glioblastoma (GLIOSUPPORT)

Glioblastoma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Quality of Life and Neurocognitive Functioning (TEMOIN)

Glioma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of the Prevalence of Pelvic Static Disorders in Women With Localized Breast Cancer (STATICBREAST)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of Sexual Quality of Life for Breast Cancer (CUPIDON2)

Quality of Life | Cancer | Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Prognostic and Predictive Value of HE4 Biomarker in Metastatic Ovarian Cancer (Meta-Four)

Metastatic Ovarian Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Medical and Surgical Management of Patients With Brain Metastases (CEREMET-LR)

Central Nervous System Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Terminated

2nd-line Treatment of Metastatic Colorectal Cancer (BEVATOMOX)

Metastatic Colorectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Effect of a Program of Physical Activity and Nutritional Therapeutic Education in Breast Cancer Patients (APAD2)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Study of Vitamin D Supplementation Tailored to Vitamin D Deficiency in Breast Cancer Patients (VITACAL)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Evaluation of Healthcare Workers Safety During Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC-Secure)

Healthy Volunteers | Safety

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Multicenter Phase 2 Trial: a Tailored Strategy for Locally Advanced Rectal Carcinoma (GRECCAR4)

Rectal Carcinoma | Locally Advanced Malignant Neoplasm

France
Institut du Cancer de Montpellier - Val d'Aurelle

Not yet recruiting

Prevention of Postoperative Complications by Negative Pressure Therapy After Complex Breast Cancer Surgery (TPN-SEIN)

Breast Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Assessment of Cardiac Coherence Associated With Medical Hypnosis on Preoperative Anxiety in Oncological Surgery (COHEC2)

Surgery | Oncology

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Study Evaluating the Tailored Management of Locally-advanced Rectal Carcinoma (GRECCAR14)

Rectal Carcinoma | Locally Advanced Malignant Neoplasm

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Creation of a Clinical Database on Primary Nervous System Tumors (BDD-NO)

Nervous System Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Predictive Toxicity Test Linked to Radiotherapy After Mastectomy and Immediate Implant Reconstruction (PRETORIA)

Breast Cancer | Capsular Contracture Associated With Breast Implant

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Predictive Value of microRNA in Thyroid Cytologies of Undetermined Type (PREDICYTHY)

Thyroid Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Identification of a New Blood Biomarker for the Diagnosis and Prognosis of Liposarcomas (ESPACE)

Liposarcoma | Atypical Lipomatous Tumor

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Liquid Biopsies and IMAging for Improved Cancer Care (LIMA)

Rectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Prospective Monocentric Clinical-biological Database (BCBPancréas)

Pancreatic Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Mouth Opening, Prevention, Education, Nutrition (OPEN) (OPEN)

Head and Neck Cancer | Trismus

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

A Clinicobiological Database in Metastatic Digestive Cancers (BCB-CBIO-DIG)

Digestive System Neoplasm

France
Institut du Cancer de Montpellier - Val d'Aurelle

Recruiting

Treatment of Malignant Peritoneal Mesothelioma (MESOTIP) (MESOTIP)

Peritoneal Carcinomatosis | Peritoneal Mesothelioma

France
Institut du Cancer de Montpellier - Val d'Aurelle

Completed

Sphincter-preserving Surgery After Preoperative Treatment of Ultra-low Rectal Carcinoma (GRECCAR1)

Rectal Cancer

France
Institut du Cancer de Montpellier - Val d'Aurelle

Active, not recruiting

Evaluation of Late Toxicity Following Intensity-Modulated Radiotherapy and Two Image-Guided Strategies With Corresponding Treatment Margins. (RCMIGI)

Prostate Cancer

France

Clinical Trials Sponsored by Institut de Génétique Moléculaire de Montpellier

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Congo, DR of

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations